Atrial fibrillation (AF or AFib) is one of the most common abnormal heart rhythms, affecting nearly 38 million people worldwide — a figure projected to nearly triple by 2030. Boston Scientific BSX ...

Atrial fibrillation, also known as AF or Afib, is one of the most common cardiovascular diseases. In fact, one in three ...

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

Shopping. Traveling. Planning family gatherings. The stress of the holiday season can make you feel like you need to slip some spirits into your hot cocoa. And at celebrations, there's often plenty of ...

A randomized clinical trial found that among people with a history of Atrial fibrillation (AFib) or related rhythm issues, drinking at least one cup of caffeinated coffee daily was associated with a ...

Nov. 18, 2025 – If you're among the 1 in 5 U.S. adults who have an abnormal heart rhythm problem called atrial fibrillation, there's been a flurry of new research about the condition that offers some ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...

Several smartwatches claim to be able to detect atrial fibrillation in wearers. But how accurate are they? That was the focus of an October meta-analysis in JACC: Advances that reviewed 28 studies ...

A recent randomized clinical trial challenges the idea that people with AFib issues may need to avoid coffee. In fact, coffee may even be protective against AFib episodes. Still, talk to your doctor ...

Coffee is the most popular beverage in the United States, with approximately two-thirds of adults consuming it daily. For people with atrial fibrillation (AFib) and those at risk for it, conventional ...

Bristol Myers Squibb and Johnson & Johnson have stopped a phase 3 anticoagulant trial early for futility, closing off one avenue to market for a molecule tipped to generate multibillion-dollar sales.

NEW ORLEANS -- For people with atrial fibrillation (Afib), there was no point cutting out coffee as it was not a disease trigger in the DECAF trial, presented here. In fact, coffee drinkers had a ...